Depression mediates impaired glucose tolerance and cognitive dysfunction: A neuromodulatory role of rosiglitazone

Hormones and Behavior

Volumn 78, Issue , 2016, Pages 200-210

  Patel, Sita Sharan ^a,b   Mehta, Vineet ^a   Changotra, Harish ^a   Udayabanu, Malairaman ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b Lakshmi Narain College of Pharmacy   (India)

Author keywords

Chronic stress; Cognition; Depression; Glucose tolerance; Rosiglitazone

Indexed keywords

APOPTOSIS INHIBITORY PROTEIN 2; AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; CATALASE; CELL PROTEIN; CORTICOSTERONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN INDUCED GENE 1 PROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; ROSIGLITAZONE; SOMATOMEDIN C RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BEHAVIOR DISORDER; CELL SURVIVAL; CHRONIC UNPREDICTABLE STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; FORCED SWIM TEST; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUT4 GENE; HIPPOCAMPUS; HYPERCORTICOSTERONEMIA; HYPOACTIVITY; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; LOCOMOTION; MALE; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL; NEUROMODULATION; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PPAR GAMMA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RISK FACTOR; SIGNAL TRANSDUCTION; STEP-THROUGH PASSIVE AVOIDANCE TEST; TAIL SUSPENSION TEST; TREATMENT DURATION; ANIMAL; ANIMAL BEHAVIOR; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; MENTAL STRESS; METABOLISM; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; COGNITION DISORDERS; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; STRESS, PSYCHOLOGICAL; THIAZOLIDINEDIONES;

EID: 84949214598     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2015.11.010     Document Type: Article

References (72)

1. Abbatecola A.M., Lattanzio F., Molinari A.M., Cioffi M., Mansi L., Rambaldi P., DiCioccio L., Cacciapuoti F., Canonico R., Paolisso G. Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. Diabetes Care 2010, 33:1706-1711.
2. Agrawal R., Tyagi E., Shukla R., Nath C. Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur. Neuropsychopharmacol. 2011, 21:261-273.
3. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:356-365.
4. Awara W.M., El-Sisi A.E., El-Refaei M., El-Naa M.M., El-Desoky K. Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes. Rev. Diabet. Stud. 2005, 2:146-156.
5. Bhutani M.K., Bishnoi M., Kulkarni S.K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol. Biochem. Behav. 2009, 92:39-43.
6. Bisaz R., Schachner M., Sandi C. Causal evidence for the involvement of the neural cell adhesion molecule, NCAM, in chronic stress-induced cognitive impairments. Hippocampus 2011, 21:56-71.
7. Cheng Y., Rodriguiz R., Murthy S., Senatorov V., Thouennon E., Cawley N.X., Aryal D.K., Ahn S., Lecka-Czernik B., Wetsel W.C., Loh Y.P. Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. Mol. Psychiatry 2015, 20:744-754.
8. Cherra S.J., Chu C.T. Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurol. 2008, 3:309-323.
9. Cheung H.H., Kelly N.L., Liston P., Korneluk R.G. Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs. Exp. Cell Res. 2006, 312:2347-2357.
10. Datusalia A.K., Sharma S.S. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation. Mol. Neurobiol. 2014, 50:390-405.
11. Detka J., Kurek A., Basta-Kaim A., Kubera M., Lasoń W., Budziszewska B. Neuroendocrine link between stress, depression and diabetes. Pharmacol. Rep. 2013, 65:1591-1600.
12. García-Bueno B., Madrigal J.L., Lizasoain I., Moro M.A., Lorenzo P., Leza J.C. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol. Psychiatry 2005, 57:885-894.
13. Ghaisas M., Navghare V., Takawale A., Zope V., Tanwar M., Deshpande A. Effect of Tectona grandis Linn. On dexamethasone-induced insulin resistance in mice. J. Ethnopharmacol. 2009, 122:304-307.
14. Gottschalk W.A., Jiang H., Tartaglia N., Feng L., Figurov A., Lu B. Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn. Mem. 1999, 6:243-256.
15. Greene-Schloesser D., Payne V., Peiffer A.M., Hsu F.C., Riddle D.R., Zhao W., Chan M.D., Metheny-Barlow L., Robbins M.E. The peroxisomal proliferator-activated receptor (PPAR) α agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiat. Res. 2014, 181:33-44.
16. Grillo C., Piroli G., Hendry R., Reagan L. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 2009, 1296:35-45.
17. Grillo C.A., Piroli G.G., Kaigler K.F., Wilson S.P., Wilson M.A., Reagan L.P. Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats. Behav. Brain Res. 2011, 222:230-235.
18. Gumuslu E., Mutlu O., Sunnetci D., Ulak G., Celikyurt I.K., Cine N., Akar F. The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice. Drug Res. (Stuttg) 2013, 63:532-539.
19. Hanley A.J., Zinman B., Sheridan P., Yusuf S., Gerstein H.C. Effect of rosiglitazone and ramipril on β-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial. Diabetes Care 2010, 33:608-613.
20. Hardman J., Limberd L. Goodman and Gilman's: The Pharmacological Basis of Therapeutics 2001, McGraw-Hill, New York. tenth ed.
21. Haynes L., Griffiths M., Hyde R., Barber D., Mitchell I. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience 2001, 104:57-69.
22. Hernandez R., Teruel T., Lorenzo M. Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes. Diabetologia 2003, 46:1618-1628.
23. Hölscher C. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Biochem. Soc. Trans. 2011, 39:891-897.
24. Hsu B.S., Fu S.H., Ku K.W., Yang T.Y., Juang J.H., Chen S.T. Enhancing islet engraftment with rosiglitazone. Transplant. Proc. 2005, 37:245-247.
25. Jatwa R., Parmar H.S., Panda S., Kar A. Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice. Basic Clin. Pharmacol. Toxicol. 2007, 101:177-180.
26. Katz R.J. Animal models and human depressive disorders. Neurosci. Biobehav. Rev. 1981, 5:231-246.
27. Katz R.J. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 1982, 16:965-968.
28. Kavak S., Ayaz L., Emre M., Inal T., Tamer L., Günay I. The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats. Cell Biochem. Funct. 2008, 26:478-485.
29. Kessler R.C., Price R.H., Wortman C.B. Social factors in psychopathology: stress, social support, and coping processes. Annu. Rev. Psychol. 1985, 36:531-572.
30. Krapivner S., Chernogubova E., Ericsson M., Ahlbeck-Glader C., Hamsten A., van't Hooft F.M. Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia 2007, 50:94-102.
31. Kuhad A., Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 2007, 576:34-42.
32. Kulkarni S., Mehta A.K. Purine nucleoside-mediated immobility in mice: reversal by antidepressants. Psychopharmacology 1985, 85:460-463.
33. Lee K.S., Park S.J., Kim S.R., Min K.H., Jin S.M., Lee H.K., Lee Y.C. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor γ in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 2006, 177:5248-5257.
34. Lin Y.H., Liu A.H., Xu Y., Tie L., Yu H.M., Li X.J. Effect of chronic unpredictable mild stress on brain-pancreas relative protein in rat brain and pancreas. Behav. Brain Res. 2005, 165:63-71.
35. Lucassen P.J., Vollmann-Honsdorf G.K., Gleisberg M., Czéh B., De Kloet E.R., Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur. J. Neurosci. 2001, 14:161-166.
36. Mahesh R., Kumar B., Jindal A., Bhatt S., Devadoss T., Pandey D.K. Antidepressant-like activity of (4-phenylpiperazin-1-yl)(quinoxalin-2-yl) methanone (4a), a novel 5-HT3 receptor antagonist: an investigation in behavior-based rodent models of depression. Indian J. Pharmacol. 2012, 44:560-565.
37. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat. Med. 2001, 7:541-547.
38. Mayat E., Petralia R.S., Wang Y.X., Wenthold R.J. Immunoprecipitation, immunoblotting, and immunocytochemistry studies suggest that glutamate receptor delta subunits form novel postsynaptic receptor complexes. J. Neurosci. 1995, 15:2533-2546.
39. Mielke J.G., Wang Y.T. Insulin, synaptic function, and opportunities for neuroprotection. Prog. Mol. Biol. Transl. Sci. 2011, 98:133-186.
40. More A.S., Kumari R.R., Gupta G., Kathirvel K., Lonare M.K., Dhayagude R.S., Kumar D., Kumar D., Sharma A.K., Tandan S.K. Effect of S-methylisothiourea in acetaminophen-induced hepatotoxicity in rat. Naunyn Schmiedeberg's Arch. Pharmacol. 2012, 385:1127-1139.
41. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
42. O'Rahilly S., Hattersley A., Vaag A., Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?. Lancet 1994, 344:585-589.
43. O'Reilly J.A., Lynch M. Rosiglitazone improves spatial memory and decreases insoluble Aβ1-42 in APP/PS1 mice. J. NeuroImmune Pharmacol. 2012, 7:140-144.
44. Pan Y., Hong Y., Zhang Q.Y., Kong L.D. Impaired hypothalamic insulin signaling in CUMS rats: restored by icariin and fluoxetine through inhibiting CRF system. Psychoneuroendocrinology 2013, 38:122-134.
45. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49:391-404.
46. Patel S.S., Udayabanu M. Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab. Brain Dis. 2014, 29:121-130.
47. Peng Y.L., Liu Y.N., Liu L., Wang X., Jiang C.L., Wang Y.X. Inducible nitric oxide synthase is involved in the modulation of depressive behaviors induced by unpredictable chronic mild stress. J. Neuroinflammation 2012, 9:75.
48. Pipatpiboon N., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C. PPARγ agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 2011, 153:329-338.
49. Piroli G.G., Grillo C.A., Reznikov L.R., Adams S., McEwen B.S., Charron M.J., Reagan L.P. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 2007, 85:71-80.
50. Potapenko E.S., Biancardi V.C., Zhou Y., Stern J.E. Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303:R291-R300.
51. Qi W.W., Zhong L.Y., Li X.R., Li G., Liu Z.X., Hu J.F., Chen N.H. Hyperglycemia induces the variations of 11β-hydroxysteroid dehydrogenase type 1 and peroxisome proliferator-activated receptor-γ expression in hippocampus and hypothalamus of diabetic rats. Exp. Diabetes Res. 2012, 2012:107130.
52. Rasgon N.L., Kenna H.A., Williams K.E., Powers B., Wroolie T., Schatzberg A.F. Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. Sci. World J. 2010, 10:321-328.
53. Rinwa P., Kumar A. Modulation of nitrergic signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations. Naunyn Schmiedeberg's Arch. Pharmacol. 2014, 387:129-141.
54. Rossetti C., Halfon O., Boutrel B. Controversies about a common etiology for eating and mood disorders. Front. Psychol. 2014, 5:1205.
55. Sadaghiani M.S., Javadi-Paydar M., Gharedaghi M.H., Fard Y.Y., Dehpour A.R. Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway. Behav. Brain Res. 2011, 224:336-343.
56. Sarkar S., Korolchuk V.I., Renna M., Imarisio S., Fleming A., Williams A., Garcia-Arencibia M., Rose C., Luo S., Underwood B.R., Kroemer G., O'Kane C.J., Rubinsztein D.C. Complex inhibitory effects of nitric oxide on autophagy. Mol. Cell 2011, 43:19-32.
57. Schubert M., Brazil D.P., Burks D.J., Kushner J.A., Ye J., Flint C.L., Farhang-Fallah J., Dikkes P., Warot X.M., Rio C., Corfas G., White M.F. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci. 2003, 23:7084-7092.
58. Sheikh N., Ahmad A., Siripurapu K.B., Kuchibhotla V.K., Singh S., Palit G. Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J. Ethnopharmacol. 2007, 111:671-676.
59. Shimizu Y., Kitagawa N., Mitsui N., Fujii Y., Toyomaki A., Hashimoto N., Kako Y., Tanaka T., Asakura S., Kusumi I. Neurocognitive impairments and quality of life in unemployed patients with remitted major depressive disorder. Psychiatry Res. 2013, 210:913-918.
60. Sousa N., Cerqueira J.J., Almeida O.F. Corticosteroid receptors and neuroplasticity. Brain Res. Rev. 2008, 57:561-570.
61. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
62. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 2004, 29:2007-2017.
63. Suwanjang W., Abramov A.Y., Govitrapong P., Chetsawang B. Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells. The J. Steroid Biochem. Mol. Biol. 2013, 138:116-122.
64. Tripathi K.D. Essentials of Medical Pharmacology 2013, Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi. seventh ed.
65. Udayabanu M., Kumaran D., Katyal A. Free chelatable zinc modulates the cholinergic function during hypobaric hypoxia-induced neuronal damage: an in vivo study. Neuroscience 2012, 202:434-445.
66. Vannucci S.J., Koehler-Stec E.M., Li K., Reynolds T.H., Clark R., Simpson I.A. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res. 1998, 797:1-11.
67. Wang L., Yu C.J., Liu W., Cheng L.Y., Zhang Y.N. Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury. Acta Pharmacol. Sin. 2011, 32:991-998.
68. Watari K., Letamendi A., Elderkin-Thompson V., Haroon E., Miller J., Darwin C., Kumar A. Cognitive function in adults with type 2 diabetes and major depression. Arch. Clin. Neuropsychol. 2006, 21:787-796.
69. Wróbel A., Serefko A., Wlaź P., Poleszak E. The depressogenic-like effect of acute and chronic treatment with dexamethasone and its influence on the activity of antidepressant drugs in the forced swim test in adult mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014, 54:243-248.
70. Yang G.Z., Gao X.P., Yan J.F., Ou K.Q., Zhao J. Mechanism of rosiglitasone to improve glucose-uptake of 3T3-L1 adipocyte with insulin resistance induced by dexamethasone and insulin. Sichuan Da Xue Xue Bao Yi Xue Ban 2007, 38:816-818.
71. Zhang X., Dong Y.L., Yang N., Liu Y.Y., Gao R.F., Zuo P.P. Effects of ning shen ling granule and dehydroepiandrosterone on cognitive function in mice undergoing chronic mild stress. Chin. J. Integr. Med. 2007, 13:46-49.
72. Zhang L., Xu T., Wang S., Yu L., Liu D., Zhan R., Yu S.Y. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice. Behav. Brain Res. 2012, 235:67-72.